Quick answer
Cancer Research Horizons is the innovation arm of Cancer Research UK. It funds translational oncology research, supports spinouts and partners with companies to commercialise CRUK-supported science. UK biotech and life sciences SMEs can engage through partnering, licensing and translational programmes.
Funding amount
Funding, licensing and partnering routes
Region
United Kingdom
Stage
Any stage
Provider
Cancer Research UK
Eligibility
UK life sciences SMEs and academic teams working in oncology, including potential CRUK spinouts.
Industries
Objectives
Regions